Increasing incidence of cardiovascular diseases worldwide is creating growth opportunities for the cardiovascular stents market, predicts Fortune Business Insights in their new study. The study is titled, “Cardiovascular Stents Market: Global Market Analysis, Insights and Forecasts, 2018 – 2025”. As per Fortune Business Insights, the market is prognosticated to exhibit 6.6% CAGR and reach a valuation of US$ 13,100.2 Mn by 2025 from US$ 7,838.9 Mn in 2017.
In terms of stent type, the drug eluting stents segment is expected to hold a larger share of the market, hence booking the dominant position. This dominance is attributable to key companies introducing next-generation drugs for drug eluting systems (DES), and is likely to continue in the coming years. With respect to end users, the hospitals segment holds dominance in the global market as it registers the highest consumption of cardiovascular stents.
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Biotronik SE & Co. KG
• Cardinal Health
• C. R. Bard, Inc.
• MicroPort Scientific Corporation
• Terumo Corporation
• B. Braun Melsungen AG
• Boston Scientific Corporation
“Increasing Number of Cardiovascular Cases to Fuel Demand in Market”
In 2017, coronary stents surgery was the most common treatment among cardiovascular patients with a market share of 66.9%. The rising number of cardiovascular diseases worldwide is expected to drive the global market, as per analysts at Fortune Business Insights. Besides this, huge investments made by market players in research and development on environmental and decomposable coronary stents is also anticipated to boost the Cardiovascular Stents Market.
Unhealthy lifestyle and irregular eating habits of people have led to have increased the prevalence of health-related concerns, including chronic diseases such as diabetes, obesity, and heart disorders. The surging cases of heart disorder is continuously fueling the demand for treating heart problems including angioplasty, which ultimately increased the demand for cardiovascular stents.
“Alpine Stent to Open Growth Opportunities for Market in Asia Pacific”
The cardiovascular stents market in North America was emerged dominant and was valued at US$ 2,344.9 Mn in 2017. This is mainly due to the presence of better medical facilities and skilled professionals in the developed nations of Canada and the U.S. North America is likely to remain dominant in the coming years as well on account of ongoing clinical trials on novel stents in the U.S. and various regulatory approvals on cardiovascular stents.
The market for cardiovascular stents in Asia Pacific is likely to show growth at a higher rate on account of improved distribution of cardiovascular stents in emerging economies such as China and India. In order to improve their accessibility, price capping of stents is introduced in these developing nations and this will help the Cardiovascular Stents Market gain momentum. Thus, Asia Pacific is likely to register itself as the fastest growing region in the during the forecast tenure.
Order Full Report@ https://www.fortunebusinessinsights.com/checkout-page/100061
Cardiovascular Stents Market Segmentation:
By Product Type
• Coronary Stenting
• Peripheral Stenting
By Stent Type
• Drug Eluting Stents (DES)
• Bioresorbable Stents
• Bare Metal Stents
• North America (USA and Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
• Latin America (Brazil, Mexico and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
More Trending Topics from Future Business Insights-
Breast Cancer Therapeutics Market Rapid Growth By Top International Players | AstraZeneca, Pfizer Inc., Sanofi, and more Forecast till 2025
Aesthetic Devices Market 2019 Global Size, Growth, Segments, Revenue, Manufacturers and Forecast by 2026